Albert J. Arias

3.6k total citations
57 papers, 2.7k citations indexed

About

Albert J. Arias is a scholar working on Cellular and Molecular Neuroscience, Epidemiology and Pharmacology. According to data from OpenAlex, Albert J. Arias has authored 57 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Cellular and Molecular Neuroscience, 23 papers in Epidemiology and 15 papers in Pharmacology. Recurrent topics in Albert J. Arias's work include Neurotransmitter Receptor Influence on Behavior (20 papers), Substance Abuse Treatment and Outcomes (20 papers) and Alcohol Consumption and Health Effects (13 papers). Albert J. Arias is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (20 papers), Substance Abuse Treatment and Outcomes (20 papers) and Alcohol Consumption and Health Effects (13 papers). Albert J. Arias collaborates with scholars based in United States, Nigeria and Canada. Albert J. Arias's co-authors include Henry R. Kranzler, Richard Feinn, Joel Gelernter, Emily Cohen, Grace Chan, Lindsay A. Farrer, Jonathan Covault, Cheryl Oncken, Raymond F. Anton and Roger D. Weiss and has published in prestigious journals such as American Journal of Psychiatry, Scientific Reports and Molecules.

In The Last Decade

Albert J. Arias

56 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert J. Arias United States 26 979 732 676 410 394 57 2.7k
Kirsten C. Morley Australia 28 736 0.8× 607 0.8× 851 1.3× 342 0.8× 321 0.8× 107 2.5k
Michael Soyka Germany 28 1.3k 1.3× 565 0.8× 720 1.1× 510 1.2× 508 1.3× 136 3.1k
Gerhard A. Wiesbeck Switzerland 34 924 0.9× 591 0.8× 776 1.1× 682 1.7× 382 1.0× 127 3.4k
Robert Miranda United States 29 1.0k 1.1× 784 1.1× 644 1.0× 261 0.6× 198 0.5× 102 2.6k
Efrat Aharonovich United States 30 1.4k 1.4× 734 1.0× 576 0.9× 285 0.7× 526 1.3× 109 3.1k
William True United States 20 733 0.7× 1.1k 1.4× 467 0.7× 219 0.5× 316 0.8× 24 2.6k
Olivier Cottencin France 30 593 0.6× 943 1.3× 532 0.8× 186 0.5× 674 1.7× 162 3.3k
George A. Kenna United States 34 779 0.8× 279 0.4× 605 0.9× 465 1.1× 234 0.6× 57 2.3k
Michael Soyka Germany 33 1.2k 1.2× 1.1k 1.5× 935 1.4× 395 1.0× 1.0k 2.5× 187 4.1k
Daniel E. Falk United States 28 1.8k 1.8× 337 0.5× 715 1.1× 861 2.1× 216 0.5× 46 3.0k

Countries citing papers authored by Albert J. Arias

Since Specialization
Citations

This map shows the geographic impact of Albert J. Arias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert J. Arias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert J. Arias more than expected).

Fields of papers citing papers by Albert J. Arias

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert J. Arias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert J. Arias. The network helps show where Albert J. Arias may publish in the future.

Co-authorship network of co-authors of Albert J. Arias

This figure shows the co-authorship network connecting the top 25 collaborators of Albert J. Arias. A scholar is included among the top collaborators of Albert J. Arias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert J. Arias. Albert J. Arias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Caitlin, James M. Bjork, Lori Keyser‐Marcus, et al.. (2024). Phase 1b/2a safety study of lemborexant as an adjunctive treatment for insomnia to buprenorphine-naloxone for opioid use disorder: A randomized controlled trial. Drug and Alcohol Dependence Reports. 14. 100304–100304. 2 indexed citations
2.
Houston, Kevin, et al.. (2024). Referral to hepatology is lower in patients with excessive alcohol use who have mental health disorders despite a high fibrosis‐4 index. Alcohol Clinical and Experimental Research. 48(10). 1898–1904. 3 indexed citations
3.
Rockwell, Michelle S., Adam Funk, Roy T. Sabo, et al.. (2024). Practice Facilitation to Address Unhealthy Alcohol Use in Primary Care. JAMA Health Forum. 5(8). e242371–e242371. 3 indexed citations
4.
Ma, Liangsuo, Kathryn A. Cunningham, Noelle C. Anastasio, et al.. (2022). A serotonergic biobehavioral signature differentiates cocaine use disorder participants administered mirtazapine. Translational Psychiatry. 12(1). 187–187. 2 indexed citations
5.
6.
Arias, Albert J., Liangsuo Ma, James M. Bjork, et al.. (2021). Altered effective connectivity of the reward network during an incentive‐processing task in adults with alcohol use disorder. Alcoholism Clinical and Experimental Research. 45(8). 1563–1577. 9 indexed citations
7.
Arias, Albert J., Christopher J. Hammond, Joseph A. Burleson, et al.. (2020). Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder. Journal of Substance Abuse Treatment. 117. 108087–108087. 9 indexed citations
8.
Kuzel, Anton J., Roy Sabo, Alicia Richards, et al.. (2020). Practice facilitation to promote evidence-based screening and management of unhealthy alcohol use in primary care: a practice-level randomized controlled trial. BMC Family Practice. 21(1). 93–93. 11 indexed citations
9.
Manhapra, Ajay, Anirban Chakraborty, & Albert J. Arias. (2018). Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review. Journal of Addiction Medicine. 13(1). 7–22. 25 indexed citations
10.
Jefee-Bahloul, Hussam, et al.. (2018). Topiramate Treatment of Alcohol Use Disorder in Clinical Practice. Journal of Addiction Medicine. 13(1). 23–27. 2 indexed citations
11.
Kranzler, Henry R., Jonathan Covault, Richard Feinn, et al.. (2014). Topiramate Treatment for Heavy Drinkers: Moderation by a GRIK1 Polymorphism. American Journal of Psychiatry. 171(4). 445–452. 143 indexed citations
12.
Niciu, Mark J. & Albert J. Arias. (2013). Targeted Opioid Receptor Antagonists in the Treatment of Alcohol Use Disorders. CNS Drugs. 27(10). 777–787. 46 indexed citations
13.
Arias, Albert J., Jonathan Covault, Richard Feinn, et al.. (2013). A GABRA2 Variant Is Associated with Increased Stimulation and ‘High’ Following Alcohol Administration. Alcohol and Alcoholism. 49(1). 1–9. 32 indexed citations
14.
Arias, Albert J. & R. Andrew Sewell. (2012). Pharmacogenetically Driven Treatments for Alcoholism. CNS Drugs. 26(6). 461–476. 12 indexed citations
15.
Wang, Fan, Arthur A. Simen, Albert J. Arias, Qunwei Lu, & Huiping Zhang. (2012). A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence. Human Genetics. 132(3). 347–358. 63 indexed citations
16.
Kranzler, Henry R., Joel Gelernter, Raymond F. Anton, et al.. (2009). Association of Markers in the 3′ Region of the GluR5 Kainate Receptor Subunit Gene to Alcohol Dependence. Alcoholism Clinical and Experimental Research. 33(5). 925–930. 52 indexed citations
17.
Kranzler, Henry R., Howard Tennen, Stephen Armeli, et al.. (2009). Targeted Naltrexone for Problem Drinkers. Journal of Clinical Psychopharmacology. 29(4). 350–357. 63 indexed citations
18.
Kranzler, Henry R., Jonathan Covault, Amira Pierucci‐Lagha, et al.. (2008). Effects of Aripiprazole on Subjective and Physiological Responses to Alcohol. Alcoholism Clinical and Experimental Research. 32(4). 573–579. 25 indexed citations
19.
Arias, Albert J., Karen L. Steinberg, Alok Banga, & Robert L. Trestman. (2006). Systematic Review of the Efficacy of Meditation Techniques as Treatments for Medical Illness. The Journal of Alternative and Complementary Medicine. 12(8). 817–832. 162 indexed citations
20.
Collado, A., et al.. (2004). Tratamiento multidisciplinar en pacientes con dolor crónico en situación de baja laboral. Revista de la Sociedad Española del Dolor. 11(4). 41–47. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsten C. Morley Breakdown of academic impact, for papers by Michael Soyka Breakdown of academic impact, for papers by Gerhard A. Wiesbeck Breakdown of academic impact, for papers by Robert Miranda Breakdown of academic impact, for papers by Efrat Aharonovich Breakdown of academic impact, for papers by William True Breakdown of academic impact, for papers by Olivier Cottencin Breakdown of academic impact, for papers by George A. Kenna Breakdown of academic impact, for papers by Michael Soyka Breakdown of academic impact, for papers by Daniel E. Falk
Rankless by CCL
2026